Parent Terms |
Term With Siblings |
Child Terms |
|
(15-Ethylidene-6-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl)methanol
(1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol
(1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol hydrochloride
(1R,9R,12R,13S,14R,16S,18R)-13-Ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
(1R,9R,13S,14R,16S,17S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
(20S)-19,20-dihydrovomilenine
(S)-carbinoxamine maleate
1,2-dehydrogeissoschizoline
10-propionyl-11-methoxy-3-methyl-carboline
11,12-methylenedioxykopsinaline
12,13-dihydroxyfumitremorgin C
19-(R)-Acetyldihydrogelsevirine
2-(17-Methoxy-11-oxa-7,20-diazahexacyclo[11.7.0.02,7.04,9.08,12.014,19]icosa-1(13),14(19),15,17-tetraen-5-ylidene)ethanol
2-\{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino\}tetralin-7-ol
2-\{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino\}tetralin-7-ol maleate
3-(methylaminomethyl)indole
4,21-dehydrogeissoschizine
5-Ethylidene-17-methoxy-11-oxa-7,20-diazahexacyclo[11.7.0.02,7.04,9.08,12.014,19]icosa-1(13),14(19),15,17-tetraene
6-(3-dimethylallyl)harmol
6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide
6-hydroxydeoxybrevianamide E
6-methoxyspirotryprostatin B
7-Ethylidene-1'-methoxy-5-methylspiro[11-oxa-5-azatricyclo[6.3.1.04,9]dodecane-2,3'-indole]-2'-one
angiotensin receptor antagonist +
benserazide hydrochloride
beta-carboline alkaloid +
bromocriptine + An indole alkaloid that has formula C32H40BrN5O5.
bromocriptine methanesulfonate
calycanthaceous alkaloid +
cariprazine hydrochloride
carmoxirole hydrochloride
cholecystokinin antagonist +
corticotropin-releasing factor receptor antagonist +
cycrimine hydrochloride +
dihydro-alpha-ergocryptine +
dihydro-beta-ergocryptine +
diphenhydramine hydrochloride
dopamine receptor D1 agonist +
endothelin receptor antagonist +
glucagon receptor antagonist +
hapalindole-type alkaloid +
indolocarbazole alkaloid +
lysergic acid diethylamide +
Methyl (12S,14S,15E)-15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylate
methyl (1R,10S,12R,13E,18R)-13-ethylidene-8,15-diazapentacyclo[10.5.1.01,9.02,7.010,15]octadeca-2,4,6,8-tetraene-18-carboxylate
Methyl (1R,4S,12S,13S,16R,18S)-18-hydroxy-17-oxo-5,14-diazaheptacyclo[12.5.3.01,13.04,12.04,18.06,11.012,16]docosa-6,8,10-triene-5-carboxylate
Methyl (9R,18R,21S)-2-methyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
Methyl 21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.112,15.01,12.03,11.04,8.019,24]tetracosa-3(11),4(8),9-triene-21-carboxylate
monodechloroaminopyrrolnitrin
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide
orphenadrine hydrochloride
piroheptine hydrochloride
pramipexole hydrochloride
pramipexole hydrochloride anhydrous +
profenamine hydrochloride
prostaglandin antagonist +
terpenoid indole alkaloid +
vasopressin receptor antagonist +
|
|
|
Synonyms |
Exact Synonyms: |
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman
|
Related Synonyms: |
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman
;
(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione
;
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman
;
2-bromo-alpha-ergocryptine
;
2-bromo-alpha-ergokryptin
;
2-bromo-alpha-ergokryptine
;
Formula=C32H40BrN5O5
;
InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1
;
InChIKey=OZVBMTJYIDMWIL-AYFBDAFISA-N
;
SMILES=[H][C@@]12Cc3c(Br)[nH]c4cccc(C1=C[C@H](CN2C)C(=O)N[C@@]1(O[C@]2(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@@]25[H])C1=O)C(C)C)c34
;
bromocriptinum
;
bromocryptine
;
bromoergocriptine
|
Xrefs: |
Beilstein:741357
;
CAS:25614-03-3
;
DrugBank:DB01200
;
Drug_Central:403
;
KEGG:C06856
;
KEGG:D03165
;
LINCS:LSM-6550
|
Xref Mesh: |
MESH:D001971
|
Xrefs: |
Patent:DE1926045
;
Patent:US3752814
;
Wikipedia:Bromocriptine |
|